VectorY Announces Participation in Scientific Conferences in October 2022
VectorY Therapeutics, a biotech company focusing on the development of innovative gene therapy approaches for the treatment of neuro-degenerative and muscular disorders through vectorized antibodies, today announces participation in three upcoming conferences.
5th Annual ALS Research Symposium (ALS ONE), 6-7 & 11 October, virtually
Presentation title: Reduction of oxidized phospholipids or misfolded protein aggregates by AAV-VecTabs in an Amyotrophic Lateral Sclerosis pre-clinical models
Presenter: Pavlina Konstantinova, Chief Scientific Officer
Time and date: October 7, 14:05 ET
European Society of Gene & Cell Therapy (ESGCT) Annual Congress, 11-14 October, Edinburgh
Poster title: VecTrons: Targeting misfolded proteins in neurodegenerative diseases
Presenter: Menno Spits, Scientist
Poster number: P251
Time and date: October 12, Poster Session 1,19:30-21:00 BST
Poster title: Generation and characterization of stable recombinant baculoviruses for large-scale production of rAAV
Presenter: Hilde van Tongeren, Head of Vector Generation
Poster number: P293
Time and date: October 12, Poster Session 1, 19:30-21:00 BST
Poster title: VecTabs® and advanced human in-vitro models: targeting TDP-43 aggregates and oxidized phosphocholines in Amyotrophic lateral sclerosis
Presenter: Andreia Duarte, Scientist
Poster number: P353
Time and date: October 12, Poster Session 1, 19:30-21:00 BST
Poster title: Next generation rAAV capsids show enhanced transduction efficiency in 2D and 3D human cellular models for neurodegenerative diseases
Presenter: Carmen Gallego, Scientist, Vector Technologies
Poster number: P056
Time and date: October 13, Poster Session 2, 17:30-19:15 BST
2022 Cell & Gene Meeting on the Mesa, 11-13 October, Carlsbad, CA
Presentation title: Precision targeted gene therapies for CNS and neuromuscular disease
Presenter: Barbara Sanders, Chief Technology Officer
Time and date: October 13,11:45 PT
To meet the VectorY team at any of these meetings, please contact [email protected].
ENDS
Notes to Editors
About VectorY
VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions for neurodegenerative and muscular diseases with high unmet medical need such as amyotrophic lateral sclerosis (ALS) and Huntington's disease.
VectorY is a fully integrated gene therapy company focused on the development of innovative therapeutics based on a novel AAV gene therapy platform, antibody-based targeted protein degradation technologies and proprietary manufacturing technology. While focusing initially on neurodegenerative and muscular diseases, VectorY's synergistic technologies may be applied across a wide range of indications.
VectoryY was founded in October 2020 and is based on the Amsterdam Science Park.
The global Ediscovery software market size is estimated to grow by USD 13.57 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 15.7% during the forecast period. Rising volume of electronic data is...
New research insights from Info-Tech Tech Research Group will equip food and beverage manufacturers with essential strategies for embracing digital transformation. The global research and advisory firm explains that the industry can significantly...
realme, the world's fastest-growing smartphone brand, today unveiled its highly anticipated ultra clear camera with AI, the realme 13 Pro Series, at the realme AI Imaging Media Preview Event in Bangkok....
Textiles is the fifth-largest category of plastic waste sent to landfills in Canada. Furthermore, through regular wear and tear and when washed, synthetic clothing sheds plastic microfibres?tiny thread-like fibres that become microplastic pollution....
ÉRIC & DANIEL TADROS, the visionaries behind the Liberty City real estate development, have received support from Tim Draper, a venture capitalist who initially funded Elon Musk for Tesla and SpaceX, and also supported over 20 companies that now...
Beatbot, the brand behind the world's most innovative pool-cleaning robots, is excited to announce its biggest consumer sale in brand history for Amazon Prime Day 2024. The brand's markdown of smart home technology will run between July 6 and July...